MedTrace Logo

User Evaluation of BGM VGM77

NCT06037512 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2023-09-14

No results posted yet for this study

Summary

Performance Evaluation by the User of the Blood Glucose Monitoring System VGM77Compliant with DIN EN ISO 15197:2015

Conditions

Interventions

DIAGNOSTIC_TEST

subject

blood glucose measurement by subject

DIAGNOSTIC_TEST

reference

blood glucose measurement with reference

Sponsors & Collaborators

  • Institut fur Diabetes Karlsburg GmbH

    lead OTHER

Principal Investigators

  • Eckhard Salzsieder, PhD · Institut fur Diabetes Karlsburg GmbH

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-13
Primary Completion
2023-06-06
Completion
2023-06-15

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06037512 on ClinicalTrials.gov